309 related articles for article (PubMed ID: 33129597)
1. Association of bioelectric impedance analysis body composition and disease severity in COVID-19 hospital ward and ICU patients: The BIAC-19 study.
Moonen HPFX; van Zanten FJL; Driessen L; de Smet V; Slingerland-Boot R; Mensink M; van Zanten ARH
Clin Nutr; 2021 Apr; 40(4):2328-2336. PubMed ID: 33129597
[TBL] [Abstract][Full Text] [Related]
2. Bioelectric impedance body composition and phase angle in relation to 90-day adverse outcome in hospitalized COVID-19 ward and ICU patients: The prospective BIAC-19 study.
Moonen HP; Bos AE; Hermans AJ; Stikkelman E; van Zanten FJ; van Zanten AR
Clin Nutr ESPEN; 2021 Dec; 46():185-192. PubMed ID: 34857194
[TBL] [Abstract][Full Text] [Related]
3. Protein requirements and provision in hospitalised COVID-19 ward and ICU patients: Agreement between calculations based on body weight and height, and measured bioimpedance lean body mass.
Moonen HP; Hermans AJ; Jans I; van Zanten AR
Clin Nutr ESPEN; 2022 Jun; 49():474-482. PubMed ID: 35623854
[TBL] [Abstract][Full Text] [Related]
4. Fat-free mass at admission predicts 28-day mortality in intensive care unit patients: the international prospective observational study Phase Angle Project.
Thibault R; Makhlouf AM; Mulliez A; Cristina Gonzalez M; Kekstas G; Kozjek NR; Preiser JC; Rozalen IC; Dadet S; Krznaric Z; Kupczyk K; Tamion F; Cano N; Pichard C;
Intensive Care Med; 2016 Sep; 42(9):1445-53. PubMed ID: 27515162
[TBL] [Abstract][Full Text] [Related]
5. Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients.
Kooistra EJ; Brinkman S; van der Voort PHJ; de Keizer NF; Dongelmans DA; Kox M; Pickkers P
Crit Care Med; 2022 Jan; 50(1):e1-e10. PubMed ID: 34374504
[TBL] [Abstract][Full Text] [Related]
6. Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020.
Kim N; Aly A; Craver C; Garvey WT
J Med Econ; 2023; 26(1):376-385. PubMed ID: 36812069
[TBL] [Abstract][Full Text] [Related]
7. Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.
Seon JY; Jeon WH; Bae SC; Eun BL; Choung JT; Oh IH
J Korean Med Sci; 2021 May; 36(20):e148. PubMed ID: 34032033
[TBL] [Abstract][Full Text] [Related]
8. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.
Gao M; Piernas C; Astbury NM; Hippisley-Cox J; O'Rahilly S; Aveyard P; Jebb SA
Lancet Diabetes Endocrinol; 2021 Jun; 9(6):350-359. PubMed ID: 33932335
[TBL] [Abstract][Full Text] [Related]
9. Association of obesity with illness severity in hospitalized patients with COVID-19: A retrospective cohort study.
Suresh S; Siddiqui M; Abu Ghanimeh M; Jou J; Simmer S; Mendiratta V; Russell S; Al-Shammari M; Chatfield A; Alsheik E; Dang D; Genaw J; Zuchelli T
Obes Res Clin Pract; 2021; 15(2):172-176. PubMed ID: 33653666
[TBL] [Abstract][Full Text] [Related]
10. Association of excess visceral fat and severe illness in hospitalized COVID-19 patients in Japan: a retrospective cohort study.
Goto Y; Nagamine Y; Hanafusa M; Kawahara T; Nawa N; Tateishi U; Ueki Y; Miyamae S; Wakabayashi K; Nosaka N; Miyazaki Y; Tohda S; Fujiwara T
Int J Obes (Lond); 2024 May; 48(5):674-682. PubMed ID: 38233538
[TBL] [Abstract][Full Text] [Related]
11. The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia.
Graziano E; Peghin M; De Martino M; De Carlo C; Da Porto A; Bulfone L; Casarsa V; Sozio E; Fabris M; Cifù A; Grassi B; Curcio F; Isola M; Sechi LA; Tascini C;
Clin Nutr ESPEN; 2022 Oct; 51():437-444. PubMed ID: 36184240
[TBL] [Abstract][Full Text] [Related]
12. The association between body mass index and severity of Coronavirus Disease 2019 (COVID-19): A cohort study.
Jayanama K; Srichatrapimuk S; Thammavaranucupt K; Kirdlarp S; Suppadungsuk S; Wongsinin T; Nanthatanti N; Phusanti S; Pitidhammabhorn D; Sungkanuparph S
PLoS One; 2021; 16(2):e0247023. PubMed ID: 33592042
[TBL] [Abstract][Full Text] [Related]
13. Visceral fat area measured by electrical bioimpedance as an aggravating factor of COVID-19: a study on body composition.
Carvalho JB; de Andrade GKP; do Nascimento LA; Golin N; Rodrigues ALCC; Suiter E; Soprani MVO; Nadolskis AS
BMC Infect Dis; 2023 Nov; 23(1):826. PubMed ID: 38001401
[TBL] [Abstract][Full Text] [Related]
14. Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden-A cohort study.
Sjögren L; Stenberg E; Thuccani M; Martikainen J; Rylander C; Wallenius V; Olbers T; Kindblom JM
PLoS One; 2021; 16(10):e0257891. PubMed ID: 34644316
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with clinical severity in emergency department patients presenting with symptomatic SARS-CoV-2 infection.
Newton S; Zollinger B; Freeman J; Moran S; Helfand A; Authelet K; McHarg M; Montano Vargas N; Shesser R; Cohen JS; Cummings DAT; Ma Y; Meltzer AC
J Am Coll Emerg Physicians Open; 2021 Aug; 2(4):e12453. PubMed ID: 34223443
[TBL] [Abstract][Full Text] [Related]
16. Hospitalization for COVID-19 is associated with significant changes in body composition.
Kellnar A; Hoppe JM; Brunner S; Stremmel C
Clin Nutr ESPEN; 2021 Oct; 45():499-502. PubMed ID: 34620361
[TBL] [Abstract][Full Text] [Related]
17. Associations between BMI and hospital resource use in patients hospitalised for COVID-19 in England: a community-based cohort study.
Altunkaya J; Piernas C; Pouwels KB; Jebb SA; Clarke P; Astbury NM; Leal J
Lancet Diabetes Endocrinol; 2024 Jul; 12(7):462-471. PubMed ID: 38843849
[TBL] [Abstract][Full Text] [Related]
18. Association between fat-free mass and survival in critically ill patients with COVID-19: A prospective cohort study.
Lakenman PLM; van Marwijk I; van der Hoven B; van Bommel J; Joosten KFM; Olieman JF
JPEN J Parenter Enteral Nutr; 2024 Feb; 48(2):192-198. PubMed ID: 38035857
[TBL] [Abstract][Full Text] [Related]
19. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
Simpson-Yap S; De Brouwer E; Kalincik T; Rijke N; Hillert JA; Walton C; Edan G; Moreau Y; Spelman T; Geys L; Parciak T; Gautrais C; Lazovski N; Pirmani A; Ardeshirdavanai A; Forsberg L; Glaser A; McBurney R; Schmidt H; Bergmann AB; Braune S; Stahmann A; Middleton R; Salter A; Fox RJ; van der Walt A; Butzkueven H; Alroughani R; Ozakbas S; Rojas JI; van der Mei I; Nag N; Ivanov R; Sciascia do Olival G; Dias AE; Magyari M; Brum D; Mendes MF; Alonso RN; Nicholas RS; Bauer J; Chertcoff AS; Zabalza A; Arrambide G; Fidao A; Comi G; Peeters L
Neurology; 2021 Nov; 97(19):e1870-e1885. PubMed ID: 34610987
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
